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Introduction {#phy212871-sec-0001}
============

Preterm birth (\<37 weeks gestation) affects around 15 million infants each year and these individuals have an increased risk of developing psychomotor and cognitive defects, especially when born before 32nd week of gestation (Colvin et al. [2004](#phy212871-bib-0014){ref-type="ref"}; Blencowe et al. [2013](#phy212871-bib-0006){ref-type="ref"}). After preterm birth, white matter injury, caused by inflammation or hemorrhage, is the most common brain pathology (Volpe [2009a](#phy212871-bib-0063){ref-type="ref"},[b](#phy212871-bib-0064){ref-type="ref"}), yet the pathophysiology and postnatal adaptation of premature brain development is complex and not understood (Krigger [2006](#phy212871-bib-0039){ref-type="ref"}). The cerebellum plays a central role for coordination of motor, vestibular, cognitive, and emotional functions (Villanueva [2012](#phy212871-bib-0062){ref-type="ref"}) and undergoes significant growth and differentiation during the late fetal and early postnatal period in infants (Dobbing and Sands [1979](#phy212871-bib-0018){ref-type="ref"}). It is highly sensitive to environmental factors and postnatal growth restriction after preterm birth (de Kieviet et al. [2012](#phy212871-bib-0036){ref-type="ref"}; Kiessling et al. [2013](#phy212871-bib-0035){ref-type="ref"}) and accordingly, cerebellum pathology is associated with cognitive and behavioral sequeale, as well as mild motor deficits (Patra et al. [2006](#phy212871-bib-0048){ref-type="ref"}; Limperopoulos et al. [2007](#phy212871-bib-0042){ref-type="ref"}).

To study the brain responses to preterm birth, it is relevant to have an animal model that allows study of brain tissues after preterm birth, in parallel with the immaturities in other organ systems (e.g., impaired lung, liver, gastrointestinal, cardiovascular, and kidney functions). In contrast to many other species, the pig shows a pre‐ and postnatal growth spurt for the brain, particularly for the cerebellum, that is comparable in timing with that in humans (Dobbing and Sands [1979](#phy212871-bib-0018){ref-type="ref"}; Conrad et al. [2012](#phy212871-bib-0015){ref-type="ref"}). Preterm pigs, born at 90% gestation, are at high risk of complications arising from their immature gastrointestinal tract and lungs (Sangild et al. [2013](#phy212871-bib-0053){ref-type="ref"}; Caminita et al. [2015](#phy212871-bib-0008){ref-type="ref"}), but it is not known if complications are also relevant for the developing brain. This question is important for the potential to use the preterm pig as an animal model in neonatal neuroscience. Functional brain deficits in preterm pigs are indicated by their impaired neonatal arousal, physical activity, balance, exploration, and cognitive function, relative to term pigs (Cao et al. [2015](#phy212871-bib-0009){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}). These effects may result from the combined effects of shorter postconceptional age and the postnatal consequences of preterm birth, for example, mild hypoxia, metabolic disturbance, and impaired growth. Interestingly, compromised neurodevelopment and cerebellar growth in preterm pigs are supported by full enteral feeding, relative to total parenteral feeding (Choudhri et al. [2014](#phy212871-bib-0013){ref-type="ref"}). Normally, preterm infants are gradually transitioned from parenteral to enteral feeding over the first week(s) after birth, but feeding regimens and diets vary widely.

We hypothesized that functional brain deficits in preterm pigs would be paralleled by developmental delays in cerebellar structure and adaptation of cerebellar gene expression, relative to pigs born at full term. Following an initial study to verify relevant functional delays of cerebellar relevance, stereology, large‐scale quantitative PCR analyses, and western blots were used to assess if postnatal development of the cerebellum differed between preterm and term pigs, and whether early initiation of enteral nutrition affected cerebellum maturation.

Materials and Methods {#phy212871-sec-0002}
=====================

Animals and their treatment {#phy212871-sec-0003}
---------------------------

All experimental procedures were approved by the National Ethics Committee on Animal Experimentation (protocol no. 2012‐15‐2934‐00193).

### Experiment 1 {#phy212871-sec-0004}

To investigate cognition‐related brain functions, preterm pigs from three litters (cesarean section at 106 days gestation, *n* = 17) were compared with pigs born naturally at full term (117--118 days, *n* = 6). The preterm pigs were reared and nourished according to a standard protocol including parenteral nutrition for the first 3 days of life (96--144 mL/kg/h, as described for Experiment 2) combined with enteral feeding with a cow′s milk based formula (32--224 mL/kg/day) until day 23. All pigs were housed individually. Preterm pigs were initially reared in oxygenated and heated incubators before transition to larger cages with a local heat lamp (3). The pigs born at full term were transported to the experimental facilities at 7 days of age and reared and fed in the same way as preterm pigs. Beginning on day 15, both preterm and term pigs were tested daily in a spatial T‐maze (build as a 'plus maze' were one arm is sealed off to form a T), previously validated for use in similar‐aged term piglets (Elmore et al. [2012](#phy212871-bib-0019){ref-type="ref"}). In the test, pigs had to learn to navigate via extra maze visual cues to obtain an accessible milk reward in one of two reward arms. For each pig, an accessible reward was placed in a fixed maze arm (e.g., east) while an equal amount of inaccessible milk was placed in the opposite arm (west) to mask olfactory cues. All piglets were tested for 6 days (10 trials/session) and the starting position in each trial within a single session was altered (north or south arm) by block randomization which ensured that the starting position was balanced within a single session. By alternating the starting position the pigs were forced to solve the maze by applying an allocentric learning strategy and use the visual cues to reach the learning criterion (80% correct). Pigs from Experiment 1 were not used for any structural or gene expression brain analyses.

### Experiment 2 {#phy212871-sec-0005}

One hundred and sixty‐eight pigs (Danish Landrace × Large White × Duroc) from eight sows were delivered by elective cesarean section at 90% gestation (*n* = 112, 106 days gestation) or 100% gestation (*n* = 56, 118 days gestation), as described in detail previously (Sangild et al. [2002](#phy212871-bib-0052){ref-type="ref"}). They were immediately transferred for individual rearing in heated and oxygenated incubators to stabilize respiration and body temperature. While still anesthetized from the cesarean section, the piglets were fitted with a vascular catheter (infant feeding tube 4F, Portex, Kent, UK) inserted into the transected umbilical artery and an orogastric feeding tube (6F, Portex). Both were secured to the skin with sutures. The piglets were initially stratified according to birth weight and sex and then randomly allocated within each stratum to receive either total parenteral nutrition (TPN group) or parenteral nutrition supplied with enteral milk nutrition (ENT group). The milk consisted of bovine colostrum (kindly donated by Biofiber Damino, Vejen, Denmark) administered every 3 h. For the TPN group, parenteral nutrition (a modified solution of Kabiven, Vitalipid, Soluvit and Vamin, all kindly donated by Fresenius Kabi, Bad Homburg, Germany) was given at 96 mL/kg/day on day 1, gradually increasing to 144 mL/kg/day on day 5. For the ENT group, enteral nutrition started at 16 mL/kg/day on day 1, increasing to 64 mL/kg/day on day 5, and this was accompanied by a reduction in parenteral nutrition such that the two dietary regimens both provided similar fluid volumes and were iso‐energetic (increasing from 74 to 110 kcal/kg/day over the first 5 days). On day five, following the critical neonatal period, a subset of the pigs was killed and tissues were collected. For the remaining pigs, the parenteral nutrition was discontinued and all piglets were given increasing amounts of full enteral nutrition with raw bovine milk (64--150 mL/kg/day providing 37--70 kcal/kg/day) for 4 days, and then transferred to fortified whole milk powder (150--200 mL/kg/day, Arla Foods, Viby J, Denmark) until day 26. Further details of the rearing procedures are available in a previous publication which also provides more details of the behavioral differences between preterm and term pigs (Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}).

Tissue collection {#phy212871-sec-0006}
-----------------

Preterm and term pigs were killed at three different time points, day of birth (day 0), day 5 or day 26, and the brains were immediately dissected (Fig. [1](#phy212871-fig-0001){ref-type="fig"}). The animals were anesthetized with zolazepam/tiletamin (Zoletil 50, Virbac, Kolding, Denmark), xylazine (Narcoxyl 20 mg/mL, MSD Animal Health, Ballerup Denmark), ketamine (Ketaminol 100 mg/mL, MSD Animal Health), and butorphanol (Torbugesic 10 mg/mL, ScanVet, Fredensborg, Denmark). The anesthetics were mixed and given as a single intra muscular injection at 0.1 mL/kg. When full anesthesia was achieved, the animals were killed with an intracardiac injection of sodium pentobarbital. The brain was carefully divided into two halves by a sharp incision through corpus callosum. All brains were macroscopically evaluated for white matter injury in the periventricular white matter. The right brain hemisphere with brain stem and cerebellum attached were collected intact and immersion‐fixed in 4% formalin for stereological analysis. The left brain part was dissected for snap freezing, including standardized sampling of the cerebellum. These cerebellar samples were immediately frozen in liquid nitrogen and stored at −80°C for subsequent analysis by western blotting and quantitative polymerase chain reaction (qPCR) analyses.

![Time lines for Experiments 1 and 2. The numbers on the preterm and term lines indicate postnatal days, whereas the numbers on the postconceptional age (PCA) line indicate postconceptional age, starting at day 106. The 12‐day difference in birth age between the groups is shown as "−12" on the line for term pigs. The T‐maze test was performed only for pigs in Experiment 1. Tissue sampling was done only for pigs from Experiment 2.](PHY2-4-e12871-g001){#phy212871-fig-0001}

Stereology on fixed tissue {#phy212871-sec-0007}
--------------------------

The stereological evaluation was based on a total of 116 cerebella from the right hemisphere. At day 0, we included *n* = 22 preterm and *n* = 11 term newborn pigs. At day 5, we included *n* = 22 preterm (12 ENT, 10 TPN) and *n* = 22 term (10 ENT, 12 TPN) pigs. At day 26, we included *n* = 17 preterm (8 ENT, 9 TPN) and *n* = 22 term (12 ENT, 10 TPN) pigs. After fixation in 4% paraformaldehyde, the brains were embedded in agar (4% agar in 1.1 mol/L phosphate buffer pH 7.4), and sectioned coronally into 2.1 mm sections. The anterior surface of each section was photographed (EOS 400D DIGITAL, Canon, Søborg, Denmark) and a total of 10--12 sections were obtained per specimen. The volumes were estimated using the Cavalieri\'s principle (Gundersen and Jensen [1987](#phy212871-bib-0022){ref-type="ref"}; Gundersen et al. [1999](#phy212871-bib-0023){ref-type="ref"}). Volume measurements were based on the NewCast Stereology software package (Visiopharm, Hørsholm, Denmark) where a point grid is placed randomly on the surface of the sections and the number of points (P) hitting the region of interest (ROI) is recorded. The volume was estimated by multiplying the total number of points hitting the ROI by the area per point, a(p), and by the thickness, T, of the slab, for example, *V* = ∑P \*a(p)\*T.

Protein extraction of frozen tissue for Western blots {#phy212871-sec-0008}
-----------------------------------------------------

Western blot analyses were performed on a total of 121 cerebelli from the left hemisphere. From day 0, we included *n* = 10 preterm and *n* = 11 term pigs. From day 5, *n* = 22 preterm (12 ENT, 10 TPN) and *n* = 22 term (10 ENT, 12 TPN) were included. Finally from day 26, *n* = 34 preterm (18 ENT, 16 TPN) and *n* = 22 term (12 ENT, 10 TPN) were included for extraction. For consistency in sampling, the same cerebellar sample was isolated and weighed (\<100 mg) and mixed with 1 ml lysis buffer (150 mmol/L NaCl, 1% Triton X‐100, 50 mmol/L Trizma Base, Sigma‐Aldrich, pH = 8.0) and 10 *μ*L protease inhibitor P8340 (Sigma‐Aldrich, Brøndby, Denmark). The tissue was homogenized using gentleMacs dissociator (Miltenyi Biotec, Lund, Sweden). The homogenate was centrifuged for 10 min at 2500 × *g* at 4°C and the supernatant transferred to an Eppendorf tube, followed by another centrifugation. Finally, the supernatant was transferred to cryo tubes and stored at −80°C.

For Western blots, 25 *μ*g protein was run by electrophoresis (Jiang et al. [2008](#phy212871-bib-0031){ref-type="ref"}) and primary antibodies against Sonic Hedgehog (Shh), Patched receptor (Ptc), Smoothened (Smo), and Gli Family Zink Finger One (Gli‐1) (Santa Cruz, Heidelberg, Germany) were used. These antibodies detected the protein density for Shh (sc‐9024), Ptc (sc‐9016), Smo (sc‐13943), and Gli‐1 (sc‐20687), respectively. The protein bands were visualized, and the density of the protein bands was detected by Quantity One (Bio‐Rad laboratories, Copenhagen, Denmark).

RNA extraction for RT‐PCR analyses {#phy212871-sec-0009}
----------------------------------

RNA was extracted from a total of 77 cerebelli. From day 0 we included *n* = 10 preterm and *n* = 11 term piglets. No RNA was extracted from Day 5 samples. From day 26, *n* = 34 preterm (18 ENT, 16 TPN) and *n* = 22 term (12 ENT, 10 TPN) animals were selected for analyses. Frozen RNA was extracted using the RNeasy Lipid Tissue Mini Kit from Qiagen (Copenhagen, Denmark). Briefly, for each sample a small piece (50--100 mg) of cerebellar brain tissue was dissected on ice and immediately transferred to gentleMacs M tubes (Miltenyi Biotec Norden, Lund, Sweden), containing 1 mL QIAzol lysis reagent. Tissue was homogenized on GentleMacs. 200 *μ*L chloroform was added and tubes were shaken vigorously for 15 sec and transferred to 2 mL Eppendorf tubes followed by centrifugation for 15 min at 12000 × *g*. The upper aqueous phase was transferred to a new Eppendorf tube with 1 volume 70% ethanol and vortexed before transfer to an RNeasy Mini spin column. The RNeasy Lipid Tissue Mini Kit protocol was subsequently followed without optional DNase step and finally RNA was eluted in 40 *μ*L RNase free water. Samples were stored at −80°C until cDNA synthesis.

Total RNA concentration and purity of samples was measured using the NanoDrop ND‐1000 spectrophotometer (Saveen and Werner AB, Sweden) and RNA integrity was assessed using the Agilent Bioanalyzer 2100 and RNA 6000 Nano Kit (Agilent Technologies, Glostrup, Denmark). All RNA integrity values (RIN) were between 5.9 and 8.5. cDNA (Qiagen array, see below) was synthesized using the RT^2^ First Strand Kit provided by Qiagen, using the Stratagene MX3000p according to the manufacturer\'s instructions. Briefly, the volume of RNA was adjusted to 500 ng and mixed with 2 *μ*L buffer GE and RNase‐free water to 10 *μ*L. This genomic DNA elimination mix was heated for 5 min at 42°C and immediately placed on ice for 2 min. Nine *μ*L reverse transcriptase mix (mixed according to manufacturer\'s instructions) was then added to the RNA mix and incubated at 42°C for 15 min, followed by 5 min at 95°C. Finally, 91 *μ*L RNase‐free water was mixed with each cDNA reaction. cDNA for Fluidigm qPCR (see below) analysis was prepared by reverse transcription of 500 ng duplicate samples of extracted total RNA using the QuantiTECT Reverse Transcription kit (Qiagen) as described previously (Skovgaard et al. [2013](#phy212871-bib-0058){ref-type="ref"}). Nonreverse transcriptase controls were included. cDNA was diluted 1:8 in low EDTA TE‐buffer (VWR, Bie & Berntsen, Denmark) prior to preamplification. Briefly, 5 *μ*L of TaqMan PreAmp Master Mix (Applied Biosystems, Nærum, Denmark), 2.5 *μ*L of primer mix (a 200 nmol/L pool of all primers used in the present study) and 2.5 *μ*L diluted cDNA was mixed and incubated at 95°C for 10 min followed by 15 cycles at 95°C for 15 sec and 60°C for 4 min. Preamplified cDNA was treated with Exonuclease I (16U, *E. coli*) (New England Biolabs, Hitchin Herts, UK) for 30 min at 37°C followed by 15 min at 80°C.

Quantitative PCR array {#phy212871-sec-0010}
----------------------

Quantitative PCR on Qiagen pathway array was performed on 16 (8 term and 8 preterm) included day 26 samples, all from the pigs that received TPN during the first 5 days. A qPCR master mix was created by mixing 102 *μ*L cDNA, 1248 *μ*L RNase‐free water and 1350 *μ*L 2xRT^2^ SYBR Green Master mix from Qiagen. A volume of 25 *μ*L of the qPCR master mix was then added to all 96 wells of the Human Neurogenesis RT² Profiler PCR Array (Qiagen Nordic, Helsinki, Finland). Array plates were sealed with optical thin wall 8‐cap strips provided by Qiagen. Plates were briefly (2 min) centrifuged at 1000 × *g* to collect contents. All 16 arrays were run with the same amplification program on the Stratagene MX3000p, according to manufacturer\'s instructions: (1) 95°,10 min (hot start), (2) 40 cycles (95°C, 15 sec, and 60°C, 1 min), (3) 95°C, 1 min and 55°C, 30 sec increasing to 95°, 30 sec (dissociation curve analysis). Results were evaluated by visual inspection of amplification and dissociation curves. Subsequently data (*C* ~q~ values) were uploaded to the online PCR analysis tool provided by Qiagen and Sabiosciences (<http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php>). Based on this, data were quality controlled. A volcano plot was created by plotting (log~10~) *P* values of a Student\'s *t*‐test versus (log~2~) fold changes (preterm/term) for each gene. The *P* values were based on Qiagen\'s array software, which does not correct for multiple testing. Genes fulfilling two criteria: (A) *P* \< 0.05 and (B) 40% upregulation (fold change \>1.40) or 40% downregulation (fold change \<0.714) in the preterm group were selected for further analysis and validation by RT‐qPCR.

Fluidigm qPCR analyses {#phy212871-sec-0011}
----------------------

Preamplified and exonuclease‐treated cDNA was diluted 1:10 in low EDTA TE‐buffer (VWR, Bie & Berntsen, Copenhagen, Denmark) before qPCR. Expression analysis was performed in two 96/96 Dynamic Array Integrated Fluidic Circuits (Fluidigm, South San Francisco, CA) using TaqMan Gene Expression Master Mix (Life Technologies, Carlsbad, CA), EvaGreen 20X (VWR), and gene‐specific primers as described previously (Skovgaard et al. [2010](#phy212871-bib-0057){ref-type="ref"}). Primers were designed in the primer3 software (<http://bioinfo.ut.ee/primer3-0.4.0/>) using similar criteria as described before (Skovgaard et al. [2010](#phy212871-bib-0057){ref-type="ref"}). The following cycle parameters were used for qPCR: 2 min at 50°C, 10 min at 95°C, followed by 35 cycles with denaturing for 15 sec at 95°C and annealing/elongation for 1 min at 60°C. Dissociation curves were generated after each run to confirm the presence of a single PCR product (from 60 to 95°C, increasing 1°C per 3 sec). Nontemplate controls and three interplate calibrators were included on each chip. Reactions were performed in duplicates (cDNA replicates). On each chip, no reverse transcriptase (minus RT) and nontemplate controls (NTC) were included to help trace possible contamination.

A detailed list of genes and associated primer sequences is presented in Table [1](#phy212871-tbl-0001){ref-type="table-wrap"}. The gene list included 10 genes selected from the Qiagen Neurogenesis array screening (Nrp1, Vegf‐A, Shh, Efnb1, Mdk, Hdac4, Erbb2, Adora2a, LOC100623510, Neurog1). Furthermore, we included additional genes for neurogenesis and angiogenesis (VEGF‐a, VEGF‐b, Dcx, Pdgfr‐beta, Flt1, Flk1, Nrp2, Pxn, Pecam1, Gpr124, Wnt7a, Wnt7b) (Solowska et al. [2002](#phy212871-bib-0059){ref-type="ref"}; Krum et al. [2008](#phy212871-bib-0040){ref-type="ref"}; Takacs et al. [2008](#phy212871-bib-0060){ref-type="ref"}; Kim et al. [2010](#phy212871-bib-0037){ref-type="ref"}; Sentilhes et al. [2010](#phy212871-bib-0054){ref-type="ref"}; Hatten and Roussel [2011](#phy212871-bib-0028){ref-type="ref"}; Hou et al. [2011](#phy212871-bib-0029){ref-type="ref"}), cerebellar maturation (Calb1, Itpr3, Gfap, Atoh1, Snf2 h, Syp) (Allais et al. [2007](#phy212871-bib-0001){ref-type="ref"}; Flora et al. [2009](#phy212871-bib-0020){ref-type="ref"}; Haldipur et al. [2011](#phy212871-bib-0024){ref-type="ref"}; Kuypers et al. [2013](#phy212871-bib-0041){ref-type="ref"}; Alvarez‐Saavedra et al. [2014](#phy212871-bib-0002){ref-type="ref"}), neurotrophic factors (Bdnf, Ntf3, Ngf, TrkB, p75) (Carter et al. [2002](#phy212871-bib-0010){ref-type="ref"}, [2003](#phy212871-bib-0011){ref-type="ref"}; Johnson et al. [2007](#phy212871-bib-0032){ref-type="ref"}), Sonic Hedgehog pathway (Shh, Ptch, Smo1), apoptosis (Lifeguard, Casp3) (Noguchi et al. [2008](#phy212871-bib-0046){ref-type="ref"}; Hurtado De Mendoza et al. [2011](#phy212871-bib-0030){ref-type="ref"}), hypoxia (HIF‐1a) (Chiral et al. [2004](#phy212871-bib-0012){ref-type="ref"}), tight junction integrity (ZO‐1, VE‐Cad, Ocln, Cldn3, Cldn5) (Silwedel and Forster [2006](#phy212871-bib-0055){ref-type="ref"}; Sadowska et al. [2010](#phy212871-bib-0051){ref-type="ref"}; Luissint et al. [2012](#phy212871-bib-0044){ref-type="ref"}; Ben‐Zvi et al. [2014](#phy212871-bib-0005){ref-type="ref"}), energy and water metabolism and transporters (Mct1, Mct2, Glut1, Glut3, Aqp4) (Nico et al. [2002](#phy212871-bib-0045){ref-type="ref"}; Dienel [2014](#phy212871-bib-0017){ref-type="ref"}), and myelination (Mbp) (Ghoumari et al. [2003](#phy212871-bib-0021){ref-type="ref"}). With few exceptions, for which validated primers already existed, two primer sets were designed for each gene targeting different locations on the mRNA transcript. We failed to obtain adequate qPCR results for Shh, Syp, Glut1, Nrp3, Hdac‐4, Neurog1, Ngf or LOC100623510.

###### 

Fluidigm qPCR primer list

  Gene Symbol/primer     Gene description                                                                                Relevance                               Sequence 5′ to 3′
  ---------------------- ----------------------------------------------------------------------------------------------- --------------------------------------- -------------------------
  Adora2a (P1), F        Adenosine A2a receptor                                                                          Qiagen array suggestion                 AGCTCCATCTTCAGCCTCCT
  Adora2a (P1), R        CCAGTCACCAAGCCATTGTA                                                                                                                    
  Adora2a (P2), F        Adenosine A2a receptor                                                                          Qiagen array suggestion                 TGCTGAGTGAAGGGAGTGTG
  Adora2a (P2), R        TTGAGGCCAGGGGACTCT                                                                                                                      
  Atoh1 (P1), F          Atonal homolog 1                                                                                Sonic Hedgehog Pathway                  GCCAGTGCAGGAGGAAAGTA
  Atoh1 (P1), R          GTAATGAGAATGCGGGGAAA                                                                                                                    
  Atoh1 (P2), F          Atonal homolog 1                                                                                Sonic Hedgehog Pathway                  CAACTGTGCAAGCTGAAAGG
  Atoh1 (P2), R          GTACCCCGTTCACCTGTTTG                                                                                                                    
  Aqp4 (P1), F           Aquaporin 4                                                                                     Water transport                         CCACGGTTCATGGAAATCTT
  Aqp4 (P1), R           TCAGTCCGTTTGGAATCACA                                                                                                                    
  Aqp4 (P2), F           Aquaporin 4                                                                                     Water transport                         TACACCGGTGCCAGTATGAA
  Aqp4 (P2), R           TGGTCCAACCCAATATATCCA                                                                                                                   
  Bdnf, F                Brain‐derived neurotrophic factor                                                               Neurotrophin                            TTGAACACGTGATCGAGGAG
  Bdnf, R                TCCGCGTCCTTATTGTTTTC                                                                                                                    
  Calb1 (P1), F          Calbindin                                                                                       Purkinje neuron marker                  GGGCAAAGAGATGATGGAAA
  Calb1 (P1), R          ATCGGAATAGCAGCAGGAAA                                                                                                                    
  Calb1 (P2), F          Calbindin                                                                                       Purkinje neuron marker                  GGAGTCAAAATGTGTGGGAAA
  Calb1 (P2), R          TGTATCCATTGCCATCCTGA                                                                                                                    
  Casp3 (P1), F          Caspase‐3                                                                                       Proapoptotic                            CTGGCAAACCCAAACTTTTC
  Casp3 (P1), R          GTCCCACTGTCCGTCTCAAT                                                                                                                    
  Casp3 (P2), F          Caspase‐3                                                                                       Proapoptotic                            AGCAGTTTTATTTGCGTGCTT
  Casp3 (P2), R          CAACAGGTCCATTTGTTCCA                                                                                                                    
  Cldn3, F               Claudin‐3                                                                                       Tight junction marker                   TTATCACAGCGCAGATCACC
  Cldn3, R               ACACTTTGCACTGCATCTGG                                                                                                                    
  Cldn5 (P1), F          Claudin‐5                                                                                       Tight junction marker                   CTGGACCACAACATCGTGAC
  Cldn5 (P1), R          AGCACCGAGTCGTACACCTT                                                                                                                    
  Cldn5 (P2), F          Claudin‐5                                                                                       Tight junction marker                   CTGGTTCGCCAACATCGT
  Cldn5 (P2), R          AAGCTTCTCCTGCTCTGCTG                                                                                                                    
  Dcx (P1), F            Doublecortin                                                                                    Neurogenesis marker                     CCTCAGGGAGTGCGTTACAT
  Dcx (P1), R            ATAGCTTTCCCCTTCCTCCA                                                                                                                    
  Dcx (P2), F            Doublecortin                                                                                    Neurogenesis marker                     TTGGTGACGACGATGTGTTT
  Dcx (P2), R            TGACTCGGCATTCATTTTCA                                                                                                                    
  Efnb1 (P1), F          Ephrin‐B1                                                                                       Qiagen array suggestion                 AAATCCGCTTCACCATCAAG
  Efnb1 (P1), R          CAGGCTCCCATTGGATGTAG                                                                                                                    
  Efnb1 (P2), F          Ephrin‐B1                                                                                       Qiagen array suggestion                 TGACCATCTTTTCCCTCCTG
  Efnb1 (P2), R          GGGCAGATGATGTCCAGTTT                                                                                                                    
  Erbb2 (P1), F          V‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2                                 Qiagen array suggestion                 CAGCACATCCACCAGGAGT
  Erbb2 (P1), R          AAGGTGCCAGTGGAGACTTG                                                                                                                    
  Erbb2 (P2), F          V‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2                                 Qiagen array suggestion                 CCCCAACACGACTCTAGCC
  Erbb2 (P2), R          GGCAACGTAGCCATCAGTTT                                                                                                                    
  Flk1 (P1), F           VEGF‐Receptor 2                                                                                 Angiogenesis pathway                    GCATCCGAAGAGCTGAAAAC
  Flk1 (P1), R           ATGCCACAGACTCCTTGCTT                                                                                                                    
  Flk1 (P2), F           VEGF‐Receptor 2                                                                                 Angiogenesis pathway                    ATCCCAGATGACAGCCAGAC
  Flk1 (P2), R           ATGGCGCTAATTTGGTTCTG                                                                                                                    
  Flt1 (P1), F           VEGF‐Receptor 1                                                                                 Angiogenesis pathway                    GAAAGGCCAAGATTTGTGGA
  Flt1 (P1), R           AGTCTTTGCCGTCCTGTTGT                                                                                                                    
  Flt1 (P2), F           VEGF‐Receptor 1                                                                                 Angiogenesis pathway                    CTACAAGCAGCCCATCACAA
  Flt1 (P2), R           CGATGAATGCACTTTCTGGA                                                                                                                    
  GFAP (P1), F           Glialfibrillaryacidic protein                                                                   (Bergmann) gliacell marker              ACATCGAGATCGCCACCTAC
  GFAP (P1), R           GCAGATTGGAGAAGGTCTGC                                                                                                                    
  GFAP (P2), F           Glialfibrillaryacidic protein                                                                   (Bergmann) gliacell marker              GCAGACCTTCTCCAATCTGC
  GFAP (P2), R           CTCCACAGTCTTCACCACGA                                                                                                                    
  Glut1 (P1), F          Glucose transporter 1                                                                           Energy metabolism                       GTCACCATCCTGGAGCTGTT
  Glut1 (P1), R          ATAGAAAACCGCGTTGATGC                                                                                                                    
  Glut1 (P2), F          Glucose transporter 1                                                                           Energy metabolism                       GCATCAACGCGGTTTTCTAT
  Glut1 (P2), R          GTGGCATACACAGGCTGCT                                                                                                                     
  Glut3 (P1), F          Glucose transporter 3                                                                           Energy metabolism                       TCCCCTCAGCTGCATTCTAT
  Glut3 (P1), R          CCAGAAGACAACGAGGAAGC                                                                                                                    
  Glut3 (P2), F          Glucose transporter 3                                                                           Energy metabolism                       GCTGGCGTGGTTAATACCAT
  Glut3 (P2), R          CTCCAAGGCCTATCAGATGC                                                                                                                    
  Gpr124 (P1), F         Probable G‐protein‐coupled receptor 124                                                         Angiogenesis regulator                  GCTGTGCTCATGGAACTGAG
  Gpr124 (P1), R         GAGAAGAGGCAGAGCAGCAG                                                                                                                    
  Gpr124 (P2), F         Probable G‐protein‐coupled receptor 124                                                         Angiogenesis regulator                  TCTGCCTCTTCTCCACCATC
  Gpr124 (P2), R         CATGTGGAAGCACAGGTTCA                                                                                                                    
  Hdac4 (P1), F          Histone deacetylase 4                                                                           Qiagen array suggestion                 CATTGACATCCACAGCCAGT
  Hdac4 (P1), R          TTCCTCGTTCTCGCACTTCT                                                                                                                    
  Hdac4 (P2), F          Histone deacetylase 4                                                                           Qiagen array suggestion                 TCTCTGCTTTGCTGGGAAAC
  Hdac4 (P2), R          CGGAGTTGTCGTAGGGTCTC                                                                                                                    
  HIF‐1a (P1), F         Hypoxia‐inducible factor 1‐alpha                                                                Hypoxia marker                          GAATGGAACGGAGCAAAAGA
  HIF‐1a (P1), R         TGATTGCCCCAGGAGTCTAC                                                                                                                    
  HIF‐1a (P2), F         Hypoxia‐inducible factor 1‐alpha                                                                Hypoxia marker                          TGTGTTATCTGTCGCTTTGAGTC
  HIF‐1a (P2), R         TTTCGCTTTCTCTGAGCATTC                                                                                                                   
  ICAM1, F               Intercellularadhesionmolecule 1                                                                 Tight junction marker                   GGGGTCCATACAGGACACTG
  ICAM1, R               CAGCTCGTACTTCTGCGACA                                                                                                                    
  Itpr3 (P1), F          Inositol 1,4,5‐Trisphosphate Receptor, Type 3                                                   Purkinje neuron differentiation         GTCATGGACGTGGAGTTCCT
  Itpr3 (P1), R          GAGGTCAAAGAGCAGGATGC                                                                                                                    
  Itpr3 (P2), F          Inositol 1,4,5‐Trisphosphate Receptor, Type 3                                                   Purkinje neuron differentiation         TCTGCTCATGTGCATTGTCA
  Itpr3 (P2), R          GGGAAGAGCGACTCATCTTTT                                                                                                                   
  Lifeguard (P1), F      Lifeguard                                                                                       Anti‐apoptotic                          TACAACACCACATCCGTGCT
  Lifeguard (P1), R      GTCGAACTTGGTCTGGAAGC                                                                                                                    
  Lifeguard (P2), F      Lifeguard                                                                                       Antiapoptotic                           GGAGCAGGCGTGTTTACATT
  Lifeguard (P2), R      TGAGGGCGCCAAAAATATAC                                                                                                                    
  LOC100623510 (P1), F   Protein S100‐B‐like (no SusScrofaortholog)                                                      Qiagen array suggestion                 AGCTCATCAACAGCGAGCTT
  LOC100623510 (P1), R   GCTGTCCAGTGTCTCCATGA                                                                                                                    
  LOC100623510 (P2), F   Protein S100‐B‐like (no SusScrofaortholog)                                                      Qiagen array suggestion                 CAGGAGGTCGTGGACAAAGT
  LOC100623510 (P2), R   GGTAACCATGGCGACAAAAG                                                                                                                    
  Mbp (P1), F            Myelin Basic Protein                                                                            Myelinization marker                    TGACTACAAACCGGCTCACA
  Mbp (P1), R            TCCCAGCTTGAAGATTTTGG                                                                                                                    
  Mbp (P2), F            Myelin Basic Protein                                                                            Myelinization marker                    GGACTGTCCCTCAGCAGATT
  Mbp (P2), R            GAGCCGGTTTGTAGTCAGGA                                                                                                                    
  Mct1 (P1), F           Monocarboxylate transporter 1                                                                   Energy (lactate) metabolism             CCGACTTCTGGCAAAAGAAC
  Mct1 (P1), R           GGCTTCTCAGCAGCGTCTAT                                                                                                                    
  Mct1 (P2), F           Monocarboxylate transporter 1                                                                   Energy (lactate) metabolism             GGTGGAGGTCCTATCAGCAG
  Mct1 (P2), R           GAAGGAAGCTGCAATCAAGC                                                                                                                    
  Mct2 (P1), F           Monocarboxylate transporter 2                                                                   Energy (lactate) metabolism             CTCACTTGGCCTCTGTGTGA
  Mct2 (P1), R           AAAGATGCCTGGCAAGAAGA                                                                                                                    
  Mct2 (P2), F           Monocarboxylate transporter 2                                                                   Energy (lactate) metabolism             GGTCCCCACCCATTAGTTTT
  Mct2 (P2), R           ATGGAGAGGGCTGAGGATTT                                                                                                                    
  Mdk (P1), F            Midkine (neurite growth‐promoting factor 2)                                                     Qiagen array suggestion                 GAAGGCTCGGTACAATGCTC
  Mdk (P1), R            TTTTCCCTTCCCTTTCTTGG                                                                                                                    
  Mdk (P2), F            Midkine (neurite growth‐promoting factor 2)                                                     Qiagen array suggestion                 GGTGGCCAAAAAGAAAGACA
  Mdk (P2), R            CACTCCGCAGTCCTTGCT                                                                                                                      
  Neurog1 (P1), F        Neurogenin 1                                                                                    Qiagen array suggestion                 GCCACTCTCTGACCCCAGTA
  Neurog1 (P1), R        AGGCCTGGAAAGGAGAAAAG                                                                                                                    
  Neurog1 (P2), F        Neurogenin 1                                                                                    Qiagen array suggestion                 CTTCCCAGACGACAGCAAG
  Neurog1 (P2), R        GCCAGAGCCCAGATGTAGTT                                                                                                                    
  Ngf (P1), F            Nerve Growth Factor                                                                             Neurotrophin                            TCAGCATTCCCTTGACACAG
  Ngf (P1), R            AAGTTTGGGGTCCACAGTGA                                                                                                                    
  Ngf (P2), F            Nerve Growth Factor                                                                             Neurotrophin                            CAACAGGACTCACAGGAGCA
  Ngf (P2), R            CTGTCGCACACCGAGAACT                                                                                                                     
  Nrp1 (P1), F           Neuropilin 1 (VEGF ligand)                                                                      Qiagen array suggestion                 TTCAAGAGGGGTCCTGAATG
  Nrp1 (P1), R           GGCTGTTGGGGTATTTTTCA                                                                                                                    
  Nrp1 (P2), F           Neuropilin 1 (VEGF ligand)                                                                      Qiagen array suggestion                 TCGAAAGCTTTGACCTGGAG
  Nrp1 (P2), R           CCAATATGGGGACCAACATC                                                                                                                    
  Nrp2 (P1), F           Neuropilin 2                                                                                    Angiogenesis pathway                    GTTACTGCCTTGCGTTCCTC
  Nrp2 (P1), R           CATCCTCGTAGCCCTCTCTG                                                                                                                    
  Nrp2 (P2), F           Neuropilin 2                                                                                    Angiogenesis pathway                    CGACATGGAGTACCAGCAGA
  Nrp2 (P2), R           GAGGAACGCAAGGCAGTAAC                                                                                                                    
  Ntf3 (P1), F           Neurotrophin 3                                                                                  Neurotrophin                            AGACTCGCTCAATTCCCTGA
  Ntf3 (P1), R           CTGAAGGTCCACCATCTGCT                                                                                                                    
  Ntf3 (P2), F           Neurotrophin 3                                                                                  Neurotrophin                            CAAAACCTCCCAGACCTACG
  Ntf3 (P2), R           ACAAGGCACACACACAGGAC                                                                                                                    
  Ocln, F                Occludin                                                                                        Tight junction marker                   GACGAGCTGGAGGAAGACTG
  Ocln, R                GTACTCCTGCAGGCCACTGT                                                                                                                    
  p75 (P1), F            Nerve Growth Factor Receptor                                                                    Neurotrophin receptor                   CGACAACCTCATCCCTGTCT
  p75 (P1), R            GCTGTTCCACCTCTTGAAGG                                                                                                                    
  p75 (P2), F            Nerve Growth Factor Receptor                                                                    Neurotrophin receptor                   CTGCAAGCAGAACAAGCAAG
  p75 (P2), R            TCTGGCTGTCCACAGAGATG                                                                                                                    
  Pdgfr‐beta (P1), F     Platelet‐derived growth factor receptor beta                                                    Tyrosinekinase receptors                CTCACCGTCATCTCCCTCAT
  Pdgfr‐beta (P1), R     AGCTCACGGATTCGATCACT                                                                                                                    
  Pdgfr‐beta (P2), F     Platelet‐derived growth factor receptor beta                                                    Tyrosinekinase receptors                GAGCCATTCTCAGGCTACCA
  Pdgfr‐beta (P2), R     GACATGAGGGCTTGCTTCTC                                                                                                                    
  Pecam‐1 (P1), F        Platelet endothelial cell adhesion molecule                                                     Endothelialcell marker                  TTGGAAACCATGCAATGAAA
  Pecam‐1 (P1), R        GGTCACTTCCACTTCCGTGT                                                                                                                    
  Pecam‐1 (P2), F        Platelet endothelial cell adhesion molecule                                                     Endothelialcell marker                  ACACGGAAGTGGAAGTGACC
  Pecam‐1 (P2), R        TCAGCTTTCCGGATTTCACT                                                                                                                    
  Ptch, F                Patched receptor                                                                                Sonic Hedgehog Pathway                  GCGTGGATGATGTTTTCCTT
  Ptch, R                GCTTGAGGCATTCTCCAGTC                                                                                                                    
  Pxn (P1), F            Paxilin                                                                                         Angiogenesis pathway                    CTCTCTCCCAGAGGGGAAAC
  Pxn (P1), R            GTGGAGTGGTCTGGCTCTTC                                                                                                                    
  Pxn (P2), F            Paxilin                                                                                         Angiogenesis pathway                    CTCCCCTGTGAACTTTCTGG
  Pxn (P2), R            TTCCTGAGAAGGCAGGAGAA                                                                                                                    
  Shh (P1), F            Sonic Hedgehog                                                                                  Sonic hedgehog pathway                  GCGACTTCCTCACCTTCTTG
  Shh (P1), R            GGCTCTCTGGTCTCGATCAC                                                                                                                    
  Shh (P2), F            Sonic Hedgehog                                                                                  Sonic hedgehog pathway                  AGCAGTTTATCCCCAACGTG
  Shh (P2), R            TGTAATTGGGGGTGAGTTCC                                                                                                                    
  Smo1, F                Smoothened receptor                                                                             Sonic Hedgehog Pathway                  CAGCAAGATCAACGAGACCA
  Smo1, R                GTGGCAGCTGAAAGTGATGA                                                                                                                    
  Snf2 h (P1), F         SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily A member 5   Purkinje and granula cell development   TACAAGGTGCCTCGAAATCC
  Snf2 h (P1), R         TCATCGTTAAGGGGTTCAGC                                                                                                                    
  Snf2 h (P2), F         SWI/SNF‐related matrix‐associated actin‐dependent regulator of chromatin subfamily A member 5   Purkinje and granula cell development   GAAAGGGGAGAGGCAAGAAT
  Snf2 h (P2), R         TGTACCGTCCAATCTTCGTG                                                                                                                    
  Syp (P1), F            Synaptophysin                                                                                   Synaptogenesis marker                   GGAATACCTGCAAGGAGCTG
  Syp (P1), R            AGAGCACCAGGTTCAGGAAG                                                                                                                    
  Syp (P2), F            Synaptophysin                                                                                   Synaptogenesis marker                   GTGACCTCTGGCCTCAACAC
  Syp (P2), R            CTCCTTGAACACGAACCACA                                                                                                                    
  TrkB (P1), F           BDNF/NT‐3 growth factors receptor                                                               Neurotrophin receptor                   TTGTGTGGCAGAAAATCTCG
  TrkB (P1), R           GGTCTGAGGTTGGAGATTCG                                                                                                                    
  TrkB (P2), F           BDNF/NT‐3 growth factors receptor                                                               Neurotrophin receptor                   GGGGCAATTTTGAATGAGTC
  TrkB (P2), R           CGTGGTACTCCGTGTGATTG                                                                                                                    
  VE‐Cad (P1), F         VascularEndothelialCadherin                                                                     Tight junction marker                   AGAGCCTCATGGGGAAGAAT
  VE‐Cad (P1), R         TCTGAGGAGAGGCTGAGGAG                                                                                                                    
  VE‐Cad (P2), F         VascularEndothelialCadherin                                                                     Tight junction marker                   AACACACCTCTGGGAAATGG
  VE‐Cad (P2), R         TGTCAAAGGGTGTGCTGAAG                                                                                                                    
  Vegf‐A, F              Vascular endothelial growth factor A                                                            Angiogenesis pathway                    ACATCTTCAAGCCGTCCTGT
  Vegf‐A, R              ACACTCCAGACCTTCGTCGT                                                                                                                    
  Vegf‐B (P1), F         Vascular endothelial growth factor B                                                            Neurotrophin pathway                    GTGAAGCCAGACAGGGTTTC
  Vegf‐B (P1), R         GTGGGATGGGTGATGTCAG                                                                                                                     
  Vegf‐B (P2), F         Vascular endothelial growth factor B                                                            Neurotrophin pathway                    CTCTGGCCACCAAAAGAAAG
  Vegf‐B (P2), R         TCCATGGTTAGAGGCACCAC                                                                                                                    
  Wnt7a (P1), F          Wingless type, member 7A                                                                        Embryogenesis and angiogenesis marker   GCCTGGACGAGTGTCAGTTT
  Wnt7a (P1), R          GCTCCCCACTTTGAGCTCTT                                                                                                                    
  Wnt7a (P2), F          Wingless type, member 7A                                                                        Embryogenesis and angiogenesis marker   ATCAAGAAGCCGCTGTCCTA
  Wnt7a (P2), R          GGTCCTCCTCGCAGTAGTTG                                                                                                                    
  Wnt7b (P1), F          Wingless type, member 7B                                                                        Embryogenesis and angiogenesis marker   CGCGAGATCAAGAAAAACG
  Wnt7b (P1), R          CACTTGCACTCCAGCTTCAT                                                                                                                    
  Wnt7b (P2), F          Wingless type, member 7B                                                                        Embryogenesis and angiogenesis marker   GCTACGGCATCGACTTCTCC
  Wnt7b (P2), R          TCGTTGTTGTGCAGGTTCAT                                                                                                                    
  ZO‐1 (P1), F           Tight junction protein 1                                                                        Tight junction marker                   ATGACTCCTGACGGTTGGTC
  ZO‐1 (P1), R           TGCCAGGTTTTAGGATCACC                                                                                                                    
  ZO‐1 (P2), F           Tight junction protein 1                                                                        Tight junction marker                   CCGCCTCCTGAGTTTGATAG
  ZO‐1 (P2), R           CAGCTTTAGGCACTGTGCTG                                                                                                                    
  Beta‐actin, F          Beta‐actin                                                                                      Reference gene                          CTACGTCGCCCTGGACTTC
  Beta‐actin, R          GCAGCTCGTAGCTCTTCTCC                                                                                                                    
  B2 m, F                Beta‐2‐microglobulin                                                                            Reference gene                          TGAAGCACGTGACTCTCGAT
  B2 m, R                CTCTGTGATGCCGGTTAGTG                                                                                                                    
  Gapdh, F               Glyceraldehyde 3‐phosphate dehydrogenase                                                        Reference gene                          ACCCAGAAGACTGTGGATGG
  Gapdh, R               AAGCAGGGATGATGTTCTGG                                                                                                                    
  PP1a, F                Protein phosphatase 1 alpha                                                                     Reference gene                          CAAGACTGAGTGGTTGGATGG
  PP1a, R                TGTCCACAGTCAGCAATGGT                                                                                                                    
  Rpl13A, F              60S ribosomal protein L13a                                                                      Reference gene                          ATTGTGGCCAAGCAGGTACT
  Rpl13A, R              AATTGCCAGAAATGTTGATGC                                                                                                                   
  Tbp, F                 Tatabox‐binding protein                                                                         Reference gene                          ACGTTCGGTTTAGGTTGCAG
  Tbp, R                 CAGGAACGCTCTGGAGTTCT                                                                                                                    

List of genes, relevance and primer sequences used for Fluidigm qPCR. P1 and P2 states the two "names" given for all newly designed primer sets. Reference genes are given as the last six in the gene list.
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Data were retrieved and inspected using Fluidigm\'s Real‐Time PCR Analysis software, version 3.0.2 and exported to GenEx5 (MultiD, Göteborg, Sweden) for data preprocessing as previously described (Skovgaard et al. [2013](#phy212871-bib-0058){ref-type="ref"}). Data normalization was performed to four highly stable reference genes. Using GeNorm (Vandesompele et al. [2002](#phy212871-bib-0061){ref-type="ref"}) and NormFinder (Andersen et al. [2004](#phy212871-bib-0003){ref-type="ref"}), Beta‐actin, GAPDH, RPL13A, and TBP were identified as stable expressed reference genes out of six candidates. For each primer assay, the lowest mean relative expression level was set to 1 and all data scaled accordingly, during data transformation from log2 (*C*q) to linear scale.

Statistics {#phy212871-sec-0012}
----------

For the analysis of each of the stereological, Western blot, and Fluidigm qPCR outcomes the three postnatal sampling time points (day 0, 5, 26), the time of birth (term vs. preterm), and the diet (ENT vs. TPN) was tested using factorial analysis of variance (ANOVA) (IBM SPSS Statistics Version 22). Bonferroni post hoc tests were used to validate any significant main effects for the Western blot and stereological data, whereas specific selection criteria were applied to the qPCR data (see below). To correlate gray and white matter growth to postconceptional age (PCA) in the presentations, newborn term piglets were considered to have a PCA of 118 days and the newborn preterm pigs a PCA of 106 days (Fig. [1](#phy212871-fig-0001){ref-type="fig"}). The PCA of other groups were then calculated by adding the respective postnatal ages (5 or 26 days, see Fig. [1](#phy212871-fig-0001){ref-type="fig"}). The effect of preterm birth on volume parameters was tested by ANCOVA using the statistical software program R (version 3.0.3), where the estimated volumes for preterm piglets at postnatal days 5 and 26 were compared with the expected volumes calculated from the normal growth curves. The normal growth curves were constructed using the volume estimates from preterm postnatal day 0 (PCA = 106 days), term postnatal day 0, 5, and 26 (PCA = 118, 123, and 144 days, respectively, Fig. [1](#phy212871-fig-0001){ref-type="fig"}). Diet effects were tested separately for the term and preterm pigs by ANOVA. A covariance analysis was performed to test, whether the gray/white matter ratio was explained by PCA or birth type (preterm/term).

In the qPCR experiments, genes were considered to be differentially expressed if *P *\<* *0.05, and if the expression changed ≥2‐fold for a single primer or ≥1.5‐fold for double primers. Due to these conservative selection criteria, no Bonferroni correction was performed on the qPCR data.

Results {#phy212871-sec-0013}
=======

Experiment 1 {#phy212871-sec-0014}
------------

In the T‐maze, all pigs initially performed according to chance on day 15 of life \[\~50% correct choices (*P* = 0.09, term vs. preterm), Fig. [2](#phy212871-fig-0002){ref-type="fig"}\]. Although all pigs improved their performance over time (*P* \< 0.001), learning was significantly delayed in preterm versus term pigs that took 3 days more to reach the learning criterion (*P* \< 0.01, 80% correct choices). In the T‐maze, both the latency to the choice of a reward arm (speed of decision making), and the total distance moved, decreased with time, but were similar between groups.

![T‐maze experiment. T‐maze test using term (black symbols, *n *= 6) and preterm (white symbols, *n *= 17) pigs. Each symbol represents average performance (mean ± SEM) of all pigs and of all ten trials for each of six consecutive days (A1--A6), starting on postnatal day 15. The term pigs reached the learning criterion (80% correct choices) 3 days before the preterm pigs (\**P *\< 0.05).](PHY2-4-e12871-g002){#phy212871-fig-0002}

Experiment 2 {#phy212871-sec-0015}
------------

Organ weights, clinical chemistry, and behavioral characteristics of the pigs have been reported in a separate publication (Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}). The preterm pigs showed a long series of signs that indicate their immature organ development at birth, including reduced body growth and liver and gut weights together with mild hypothermia, hypoxia, and hypoglycemia during the first few days after birth (Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}).

### Cerebellar volumes {#phy212871-sec-0016}

Macroscopical evaluation of the brains collected from both preterm and term pigs at all three ages (0, 5, and 26 days) and after different treatments for the first 5 days (TPN, ENT) revealed no visible signs of brain injury, for example, white matter injury, hemorrhage, or apparent inflammatory lesions. There were no significant effects of the diet interventions (TPN, ENT) during the first 5 days on any of the investigated volumetric parameters (data not shown). Because of the minimal effects of diet during the first 5 days, data for the two diet regimens were pooled in the subsequent statistical analyses, as shown in Figure [3](#phy212871-fig-0003){ref-type="fig"}.

![Postnatal comparison of cerebellar volumes. For both white matter (A) and gray matter (B), the cerebellar volumes were smaller for preterm (gray bars), relative to term (white bars) pigs at all measured ages (\**P *\< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001). The gray/white matter ratio (C) was higher in preterm pigs at birth (\**P *\< 0.05).](PHY2-4-e12871-g003){#phy212871-fig-0003}

Comparison between preterm and term pigs showed significant differences for white matter (Fig. [3](#phy212871-fig-0003){ref-type="fig"}A) and gray matter (Fig. [3](#phy212871-fig-0003){ref-type="fig"}B) at postnatal day 0, 5, and 26, respectively (*P* \< 0.001--0.05). The gray to white matter ratio was significantly higher in preterm pigs, relative to term pigs on day 0 (*P* \< 0.05, Fig. [3](#phy212871-fig-0003){ref-type="fig"}C). Across preterm and term pigs, the cerebellar gray and white matter volumes both increased significantly with age (*P* \< 0.0001). We therefore generated a linear fit through P0, T0, T5, and T26 representing the normal growth of gray and white matter, respectively, and tested whether the observed means for P5 and P26 differed from the expected means. The observed means for P5 and P26 were not significantly different from the expected (*P* \> 0.05). Analyzed across preterm and term piglets according to their PCA, the estimated gray matter volume increased by 0.02 cm^3^ per day, corresponding to an increase of 65% from 12 days before normal term to 26 days after birth (1.33 ± 0.32 to 2.17 ± 0.29 cm^3^, Fig. [4](#phy212871-fig-0004){ref-type="fig"}). The estimated white matter volume increased by only 0.01 cm^3^, yet due to the smaller absolute levels of white matter, this corresponded to a total growth of 108% from 12 days before term to 26 days after birth (0.31 ± 0.11 to 0.65 ± 0.11 cm^3^). The gray/white matter ratio decreased with increasing PCA (*P* \< 0.01, *R* ^2^ = 0.09, data not shown). This decrease was not different between terms and preterms (*P* = 0.09), but rather correlated to PCA (*P* \< 0.05, data not shown).

![Development of cerebellar gray and white matter volumes. Each symbol shows a volume estimate for a single pig (black circles = gray matter, open circles = white matter. Dotted lines display the linear fit of volume as a function of postconceptional age of PCA 106, 118, 123, and 144 corresponding to preterm postnatal age 0, and term postnatal ages 0, 5, and 26 days. The shaded gray area shows the prediction intervals for the linear fits. The black bars shows means ± confidence intervals for PCA 111 and 132, corresponding to preterm postnatal age 5, and 26 days. The observed means for PCA 111 and 132 were not significantly different from the expected values calculated from the growth curves (*P *\> 0.05). The total relative growth from 90% gestation to 26 days in term pigs was 108 and 64% for white and gray matter, respectively.](PHY2-4-e12871-g004){#phy212871-fig-0004}

### Sonic hedgehog pathway proteins {#phy212871-sec-0017}

Neither Shh protein level nor its downstream pathway factors, Smo and Gli‐1, showed any significant differences between preterm and term pigs at any of the three time points (data not shown). We found no effect of the diet interventions during the first 5 days (TPN, ENT) on the sonic hedgehog pathway, nor on the postnatal development during the first 26 postnatal days (data not shown).

### qPCR gene expression analyses {#phy212871-sec-0018}

Ten of the 84 tested Qiagen array genes fulfilled our predefined selection criteria at day 26. Eight genes were significantly upregulated in preterm versus term pigs (*P* \< 0.05), here presented with their corresponding fold changes (FC): Ephrin‐B1 (+1.5), Neuropilin 1 (+1.5), Sonic Hedgehog (+1.6), Histone Deacetylase 4 (+1.6), V‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2 (+1.6), Vascular endothelial growth factor A (+1.7), Adenosine receptor 2a (+2.2), and Midkine (+2.2). Two genes were significantly downregulated (*P* \< 0.05): Neurogenin 1 (0.6) and Protein S100‐B‐like (0.4). These ten target genes were subsequently included in the qPCR analyses of day 0 (*n* = 21) and day 26 (*n* = 56) animals.

The Fluidigm qPCR comprised a total of 49 genes, with six reference genes and 33 additional genes of relevance for cerebellar development. The qPCR results showed no consistent significant interactions among age (0 vs. 26 days), diet (TPN vs. ENT), or birth type effects (term vs. preterm) for any of the tested genes. Consequently, the results could be summarized as the gene expression ratios for day 26 versus day 0, and for preterm versus term pigs on day 0 and day 26, respectively (Table [2](#phy212871-tbl-0002){ref-type="table-wrap"}). The majority of analyzed genes showed either no differential regulation or regulation below our inclusion criteria (*P* \< 0.05 and concomitant gene expression fold change \>2‐ or \>1.5‐fold or \<0.5‐ or \<0.75‐fold for single or double primer sets, respectively). Genes showing increased expression between birth and day 26 were Bdnf, Ntf3, and Hif‐1a (*P* \< 0.01), whereas significant decreases were observed for p75, Atoh‐1, Icam‐1, Dcx, Efnb1, and Nrp1 (*P* \< 0.01). Preterm pigs showed upregulation of five genes at birth (Mdk, Ntf3, p75, Efnb1, and Dcx, +40--90%, *P* \< 0.01), relative to term pigs, and three of these continued to show upregulation at day 26 (Mdk, p75, Ntf3, +40--70%, *P* \< 0.01). No genes were downregulated in preterm pigs, relative to term pigs, neither at birth nor after 26 days.

###### 

qPCR results

  Gene category/annotation         Gene                                               Day 26/Day 0 (Preterm + Term)                      Preterm/term (Day 0)                               Preterm/term (Day 26)
  -------------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- -----------------------
  Neurotrophic factors/receptors   Bdnf                                               2.1[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Ntf3 (P1)                        1.5[\*](#phy212871-note-0003){ref-type="fn"}       1.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Ntf3 (P2)                        2.1[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.9[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.7[\*\*](#phy212871-note-0003){ref-type="fn"}     
  p75 (P1)                         0.7[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.4[\*\*](#phy212871-note-0003){ref-type="fn"}     
  p75 (P2)                         0.7[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.7[\*\*\*](#phy212871-note-0003){ref-type="fn"}   
  Neurogenesis/angiogenesis        Dcx (P1)                                           0.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}   
  Dcx (P2)                         0.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Efnb1 (P1)                       0.7[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Efnb1 (P2)                       0.6[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Mdk (P1)                                                                            1.6[\*\*\*](#phy212871-note-0003){ref-type="fn"}   1.7[\*\*\*](#phy212871-note-0003){ref-type="fn"}   
  Mdk (P2)                                                                            1.4[\*\*](#phy212871-note-0003){ref-type="fn"}     1.6[\*\*\*](#phy212871-note-0003){ref-type="fn"}   
  Nrp1 (P1)                        0.7[\*\*](#phy212871-note-0003){ref-type="fn"}                                                                                                           
  Nrp1 (P2)                        0.7[\*](#phy212871-note-0003){ref-type="fn"}                                                                                                             
  Hypoxia                          Hif‐1a (P1)                                        1.4[\*](#phy212871-note-0003){ref-type="fn"}                                                          
  Hif‐1a (P2)                      1.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                                                                         
  Sonic hedgehog pathway           Atoh1                                              0.5[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      
  Tight junction                   Icam1                                              0.4[\*\*\*](#phy212871-note-0003){ref-type="fn"}                                                      

Ratios of mean values of Day26/Day0 and Preterm/Term for differentially expressed genes by Fluidigm qPCR. \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001. Blank cell = not significant (*P* \> 0.05) or 0.75/0.5 \< mean expression value ratio \<1.5/2 for 2 or 1 primer sets, respectively. Note that for p75, Efnb1, Dcx, and Mdk, a borderline mean value ratio of 1.4 was included.
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We recently demonstrated that preterm pigs show distinct behavioral and motor coordination delays relative to term pigs during the first weeks after birth (Cao et al. [2015](#phy212871-bib-0009){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}). Together with the inferior performance of preterm pigs in the T‐maze in this study, this verifies the functional neurodevelopmental delay in preterm pigs. It was surprising that these functional differences were not associated with more clear structural or molecular changes in the preterm pig cerebellum. Except for a few potentially important differences, preterm and term pigs did not differ markedly in cerebellum morphology, white to gray matter ratios, and the protein abundance and expression of a large number of genes considered important for brain maturation. Our endpoints were investigated in a state of relatively slow growth for both preterm and term pigs. This was caused by a need to standardize the feeding regimens between preterm and term piglets for optimal comparison, thus term piglets were fed at the same relatively low feed intake, as for preterm pigs, leading to relatively slow growth. In addition, the cesarean section, lack of initial sow rearing (colostrum uptake) and artificial rearing may have contributed to slow growth, not only for the preterm but also for the term piglets (Cao et al. [2015](#phy212871-bib-0009){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}).

The lack of clear effects of preterm birth and the first enteral nutrition on our endpoints indicates that the preterm pig brain is relatively mature and resilient at 90% gestation, despite that other critical organs (lungs, gastrointestinal, liver) are clearly immature at this time (Sangild et al. [2013](#phy212871-bib-0053){ref-type="ref"}; Caminita et al. [2015](#phy212871-bib-0008){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}). The preterm 90% gestation piglet is considered to have an overall survival capacity that is similar to 28--30 week‐old infants (Sangild et al. [2013](#phy212871-bib-0053){ref-type="ref"}), but specifically for the developing brain, the 90% gestation piglet may be more similar to "late preterm infants" (e.g., 34--37 weeks gestation). Regardless, it remains difficult to compare structural and functional organ development in relation to birth among different species because the age‐related maturation varies among organs and also among different regions and cell populations within the same organ.

One of the questions addressed in the present study was whether postconceptional (PCA) effects or postnatal effects (environmental triggers) appeared to be most important as regulators of postnatal brain (i.e., cerebellar) development in the preterm pig. This distinction is important for the interpretation of the relatively few, significant structural and molecular differences that we observed in our study. In preterm pigs, we observed reduced gray and white matter cerebellar volumes during the first postnatal month, and higher gray to white matter ratio at birth. Correspondingly, there was a relatively larger increase in white matter than in gray matter volumes from 12 days before normal term to 26 days after term birth, when data were viewed relative to the date of conception. Postconceptional age, rather than being born preterm or term, seemed to explain the major part of the variation of the gray/white matter ratio. In contrast to the brain, maturation of the gut is always affected immediately after birth, preterm or term, partly mediated by the exposure to nutritional and microbiota triggers (Sangild et al. [2013](#phy212871-bib-0053){ref-type="ref"}). These environmental triggers have short‐ or long‐term effects on the developing gut depending on each specific structure or function (Hansen et al. [2016](#phy212871-bib-0026){ref-type="ref"}). Perhaps the brain is better protected by the meninges and the blood--brain barrier, and postnatal triggers are therefore less likely to have an immediate and strong effect on CNS development, beyond the genetic developmental program mainly determined by the PCA. Comparison of brains from groups of 12 d‐old preterm pigs with those of term newborn pigs would have helped these evaluations but such PCA‐matched groups were not included in our study. In the postnatal period, we chose to collect brains on day 5 for both groups because here preterm pigs become fully mobile, have a stable metabolism and respiration and show marked gut maturational responses to enteral feeding (Sangild et al. [2013](#phy212871-bib-0053){ref-type="ref"}; Cao et al. [2015](#phy212871-bib-0009){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}; Hansen et al. [2016](#phy212871-bib-0026){ref-type="ref"}).

The fact that cerebellar white matter grows faster than gray matter in the perinatal period of preterm pigs suggests that processes involving myelination or glial cell neurogenesis is important in the preterm cerebellum during the first postnatal month. These results are consistent with the observed increased cerebral white matter myelination in normal pigs (Winter et al. [2011](#phy212871-bib-0065){ref-type="ref"}) and with the abnormal cerebellar white matter development in preterm infants (Hart et al. [2010](#phy212871-bib-0027){ref-type="ref"}). Several recent MRI‐based studies of preterm infants have demonstrated significant correlations between cerebellar volume and cognitive performance in infancy, early childhood, adolescence, or early adulthood (van Kooij et al. [2012](#phy212871-bib-0038){ref-type="ref"}; Nosarti et al. [2014](#phy212871-bib-0047){ref-type="ref"}; Keunen et al. [2016](#phy212871-bib-0034){ref-type="ref"}). Furthermore, sex differences in cognitive performance (boys performing worse) of 30‐month‐old preterm infants also showed significant correlations with cerebellar volume estimates (Skiold et al. [2014](#phy212871-bib-0056){ref-type="ref"}), emphasizing the importance of this brain region, not only for motor purposes, but also for higher ranking brain functions.

The majority of the vast number of carefully selected neurodevelopmental genes did not differ in mRNA expression levels between preterm and term pigs. Nevertheless, mRNA levels of Neurotrophin 3, p75 neurotrophin receptor, and Midkine were consistently higher in preterm pigs throughout the first 4 weeks, whereas Doublecortin and Ephrin‐B1 were higher at day of birth. For these genes, cerebellar expression therefore seems to decrease significantly over the extra 12 days of intrauterine life for the term piglets. Our comprehensive list of analyzed genes was based on a combination of thorough literature searches and a commercial neurogenesis array screen but we cannot exclude that potentially interesting genes could have been missed. We recently repeated the cerebellum qPCR experiment using the same gene list for a new set of 3 week‐old term and preterm pigs and results were very similar to this study with a relatively small number of genes differentially regulated between preterm and term pigs (A. Bergström, K. Ryom, K. Skovgaard, T. Thymann & P.T. Sangild unpublished results).

All ten genes that differed in expression between birth and 26 days showed no difference in response to gestational age at birth (preterm, term) or introduction of enteral nutrition (ENT) during the first 5 days, relative to pigs fed total parenteral nutrition (TPN). It was recently demonstrated that 10 days of TPN in preterm pigs leads to decreased cerebellar volume, reduced motor activity and decreased myelination, relative to full enteral milk feeding (120--200 mL/kg/day) (Choudhri et al. [2014](#phy212871-bib-0013){ref-type="ref"}). Consequently, 5 days of minimal enteral nutrition with bovine colostrum (0--60 mL/kg/day) may have been insufficient to affect cerebellar development, relative to TPN, in this study.

The observed qPCR fold changes expressed relative to postconceptional age suggests that preterm birth and its postnatal consequences stimulate a regulatory cascade of events that involves accelerated white matter growth, probably to catch up with inadequate neuronal signaling. This process of axonal myelination would be mediated by specific angiogenesis and neurogenesis markers (Mdk, Efnb1, Dcx) and neurotrophic factors (Ntf3, p75) (Kadomatsu et al. [2014](#phy212871-bib-0033){ref-type="ref"}) and is relevant in the context of preterm infants (Brew et al. [2014](#phy212871-bib-0007){ref-type="ref"}). Axon myelination by oligodendrocytes in the developing white matter is a very energy demanding process and has been shown to correlate strongly with angiogenesis and tissue oxygenation (Yuen et al. [2014](#phy212871-bib-0067){ref-type="ref"}). This may involve increased myelinization of central cerebellar neurons, for example, Purkinje and granula cells, supporting the maturation of motor, balance, and coordination functions (Wyatt et al. [2005](#phy212871-bib-0066){ref-type="ref"}).

Sonic hedgehog (Shh), expressed by the Purkinje cells during development, is believed to play a crucial role in the differentiation of both Purkinje neurons and Bergman glia cells (Rakic and Sidman [1970](#phy212871-bib-0050){ref-type="ref"}; Dahmane and Ruiz i Altaba [1999](#phy212871-bib-0016){ref-type="ref"}), thereby playing a central role in cerebellar development (Volpe [2009b](#phy212871-bib-0064){ref-type="ref"}). Shh and Bdnf are known to have a mitogenic effect on the granule cell precursors of the so‐called external granular layer (Haldipur et al. [2011](#phy212871-bib-0024){ref-type="ref"}, [2012](#phy212871-bib-0025){ref-type="ref"}). In preterm infants, advancing postnatal age negatively affects cerebellar Shh pathway activity (Haldipur et al. [2011](#phy212871-bib-0024){ref-type="ref"}). This could not be demonstrated in our study on Shh proteins in pigs during the final part of gestation or in the postnatal period of preterm pigs.

The apparent absence of macroscopic white matter injury in both groups, and lacking differences in proteins related to the sonic hedgehog pathway, or in gene expressions related to hypoxia, ischemia, tight junction integrity, glucose/lactate metabolism, apoptosis, or myelination suggest that the preterm pig cerebellum is relatively resilient to the physiological stressors just after preterm birth and to environmental stimuli such as enteral feeding and bacterial colonization. The delay in acquisition of basic motor skills, reduced physical activity, and inferior balance, coordination and cognitive capacities in preterm pigs (Cao et al. [2015](#phy212871-bib-0009){ref-type="ref"}; Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}) may therefore be determined mainly by an age‐related developmental delay, rather than by inappropriate responses to environmental factors such as enteral feeding, gut bacterial colonization, inflammation, dysmetabolism, or hypoxia after preterm birth. This is important because it indicates the degree to which optimal care and associated morbidities can be expected to influence brain development in preterm neonates, beyond the maturation occurring as a result of advancing age pre‐ and postnatally. Future model studies in preterm pigs should investigate more brain regions and environmental factors with analyses matched for both PCA and chronological age for longer periods.

The 90% gestation preterm pig may have several advantages as a model to study brain development in late preterm infants, relative to models in sheep or rodents. Both term (Elmore et al. [2012](#phy212871-bib-0019){ref-type="ref"}; Liu et al. [2014](#phy212871-bib-0043){ref-type="ref"}; Radlowski et al. [2014](#phy212871-bib-0049){ref-type="ref"}) and preterm pigs (Andersen et al. [2016](#phy212871-bib-0004){ref-type="ref"}) show great cognitive potential and the pig may be the only model animal that displays a perinatal synaptogenetic timing that is similar to that in infants (Dobbing and Sands [1979](#phy212871-bib-0018){ref-type="ref"}). Pigs have large litter sizes and better allow for long‐term medical and nutritional interventions, relative to preterm lambs or rodents. An ability to combine shortened gestational age at birth with the postnatal consequences of preterm birth (e.g., respiratory, metabolic, gut, and immunological challenges) is critical for a good model of preterm birth.
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